Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
PRNewswire - December 1, 2008
GORLITZ, Germany, December 1/PRNewswire/ -- German biotech company Partec is expanding its global leadership in specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and emerging countries. In the year 2008, 2.5 million patient tests have been performed with the portable, robust and highly affordable "CyFlow" system, supporting already more than 1 million people living with HIV/AIDS. Due to introduction of the Partec innovation, the average cost of EUR 160 per year and per patient could be reduced by a factor 20 to EUR 8, only.
The "CyFlow" instruments are being successfully used in nearly all Sub-Saharan African countries. Furthermore, the technique is being applied in Asia, Latin America, Europe and the U.S. In December 2008, the thousandth "CyFlow" device will be placed since introduction at the XVI. International AIDS Conference in Barcelona in July 2002.
By precisely measuring the CD4 T-lymphocyte concentration from blood samples, the "CyFlow" delivers accurate information about the immune status level of HIV/AIDS patients. This test is necessarily required as basis for antiretroviral therapy targeting to stabilize the immune status which is essential for survival. Approximately, 33 million people worldwide are living with HIV/AIDS. More than 95% of them reside in developing countries, especially in Africa and Asia.
On World AIDS Day 2008 Partec announces Award
On World Aids Day on 1st December, Partec announces a global award competition for NGO projects being active in the fight against HIV/AIDS. The award winner will be supported one year free of cost with the required diagnostics from Partec. Until 31st March 2009, applicants may submit a detailed project description including an explanatory statement why specifically their project should be chosen. Further information are available online at www.partec.com/worldaidsday. Applications should be directed by e-mail to worldaidsday@partec.com oder by telefax to +49-3581-874670.
Technologically, the "CyFlow" is based on the invention of fluorescence-based "flow cytometry" by Professor Wolfgang Gohde from German University of Munster. The worldwide first patent application in flow cytometry was filed almost exactly 40 years ago in December 1968. Since then, the key technology of Gohde has become a standard method for automated blood cell and cancer cell analysis in hospitals worldwide.
More information: http://www.partec.com Source: Partec GmbH
Media Contact:, Partec GmbH, Germany, Claudia Khmel, Fax: +49-3581-8746-70, E-Mail: c.khmel@partec.com
081201
PR081201
Copyright © 2008 - PRNewswire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through PRNewswire, Permissions, 810 Seventh Ave., 32nd Floor, New York, NY 10019 http://www.prnewswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .